Overview
- 47 inspections across 46 sites are on record.
- 118 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
47
Sites
46
Observations
118
Career since
Feb 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Osteal Therapeutics Inc | 7 May 2026 | Human Drugs | |
| Prithviraj Bose, M.D. | 30 Apr 2026 | Human Drugs | On file |
| University of Texas at Arlington IRB | 17 Apr 2026 | Medical Devices & Rad Health | |
| Divyansu Patel, MD | 20 Mar 2026 | Human Drugs | |
| Gul Basaran | 20 Feb 2026 | Human Drugs |
Sites inspected
Osteal Therapeutics IncDallas, United States1 insp.
Prithviraj Bose, M.D.Houston, United States1 insp.
University of Texas at Arlington IRBArlington, United States1 insp.
Divyansu Patel, MDAustin, United States1 insp.
Gul BasaranAltunizade, Turkey1 insp.
Co-investigators
Investigators who share inspections with this person.
Travis M Beard4 shared
Habacuc V Barrera3 shared
Roy Baby3 shared
Joanne M Schlossin2 shared
Iris C Macinnes2 shared
Christine I Shaw2 shared
Janet Pulver2 shared
Stephen R Souza2 shared
Andrace Deyampert1 shared
Scott B Laufenberg1 shared
Full investigator report
Get the verbatim findings behind Terri E Gibson's 118 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site